openPR Logo
Press release

Age-Related Macular Degeneration Market Historical Analysis by Global Key Players, Industry Analysis and 2023 Future Forecasts

07-02-2018 11:26 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Age-Related Macular Degeneration Market

Age-Related Macular Degeneration Market

Age-Related Macular Degeneration Market Research Objectives

This MRFR study offers a vivid view of the global Age-Related Macular Degeneration (AMD) Market. The study includes an in-depth analysis of macro and micro-economic factors likely to influence the market during the forecast period (2018-2023). It further summarizes the key market opportunities and trends.

Age-Related Macular Degeneration Market Segmentation:

The Global Age-Related Macular Degeneration Market is segmented by type, drug, route of administration, treatment, and end-user.

On the basis of type, the global age-related macular degeneration market is segmented into dry age-related macular degeneration and wet age-related macular degeneration

On the basis of drug, the global age-related macular degeneration market is segmented into Eylea, Visudyne, Lucentis, Avastin, and others.

On the basis of route of administration, the global age-related macular degeneration market is segmented into intravenous, intravitreal and others.

On the basis of treatment, the global age-related macular degeneration market is segmented into medications, devices, surgery, and others. The medication segment is further classified into anti-VEGF drugs, blood vessel growth inhibitors, vitamins, dietary supplements, and others. The devices segment is classified into corrective lens, glasses, contact lenses and others.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5736 .

Worldwide Age-Related Macular Degeneration Market Key Players:

Novartis International AG (Switzerland),

Alcon Vision Care (U.S.),

Bayer AG (Germany),

Acucela Inc. (U.S.),

Neurotech Pharmaceuticals Inc. (U.S.), 

Ophthotech Corporation (U.S.),

GlaxoSmithKline Plc (U.S.)

Alimera sciences Inc. (U.S.),

StemCell Inc. (Canada),

F. Hoffmann-La Roche Ltd. (Switzerland)

Regeneron Pharmaceutical Inc. (U.S.)

Allergan Plc (Ireland),

Adverum Biotechnologies Inc. (U.S.),

Gilead Sciences Inc. (U.S.),

Iconic Therapeutics Inc. (U.S.),

Lpath Inc. (U.S.),

OHR Pharmaceutical Inc. (U.S.),

Bausch + Lomb (U.S.),

Opthea Limited (Canada),

PanOptica, Inc. (U.S.),

Pfizer Inc. (U.S.),

Neurotech Pharmaceuticals, Inc. (U.S.),

Promedior, Inc. (U.S.),

QLT Inc. (Canada), Quark (U.S.),

Resolvyx Pharmaceuticals Inc. (U.S.),

RXi Pharmaceuticals Inc. (U.S.),

Sagent Pharmaceuticals, Inc. (U.S.),

Santen Pharmaceutical Co., Ltd. (Japan),

Sanwa Kagaku Kenkyusho (Japan) and others.

Age-Related Macular Degeneration Market Regional Analysis:

The Global Age-Related Macular Degeneration Market consists of four regions such as the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas region accounted for the largest market share of the global age-related macular degeneration market owing to the growing occurrence of age-related macular degeneration in the South American region, eye disorders among the adolescents, and the rising awareness about its long-term effects. According to the American Macular Degeneration Foundation, around 85 to 90% of the cases of macular degeneration are considered as dry AMD, whereas 10 to 15% are categorized under wet AMD.

The European region accounted for the second largest market owing to factors such as the rising geriatric population and the increasing prevalence of eye disorders such as stargardt disease, different types of macular degenerations, and diabetic retinopathy. The Asia Pacific region is anticipated to witness a fast growth during the forecast period for the global age-related macular degeneration market.

The Middle Eastern region is anticipated to grow at a steady pace owing to factors such as growing emphasis on new drug developments, rising R&D activities in the healthcare sector, and extensive development of healthcare infrastructure.

Get Discount @ https://www.marketresearchfuture.com/check-discount/5736 .

Major Table of Contents for Age-Related Macular Degeneration Market:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Treatment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

TOC Continued….!

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/5736 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Age-Related Macular Degeneration Market Historical Analysis by Global Key Players, Industry Analysis and 2023 Future Forecasts here

News-ID: 1105310 • Views:

More Releases from Market Research Future

Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics: Advancing Eye Care Through Targeted Treatment Ophthalmic topical therapeutics have become a cornerstone in modern eye care, offering precise, localized treatment for a wide range of ocular conditions. Unlike systemic medications, which circulate throughout the body and may produce unintended side effects, topical therapies deliver active compounds directly to the eye, ensuring higher efficacy and a faster onset of action. This localized approach not only improves treatment outcomes
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps: Transforming the Way We Care for Our Minds In recent years, mental health has gained increasing recognition as an essential component of overall well-being. Despite growing awareness, many individuals still face barriers to accessing mental health support, including stigma, cost, and geographic limitations. Mental health apps have emerged as a transformative solution, leveraging technology to provide accessible, personalized, and convenient mental health care for millions worldwide. The Rise of
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves: A Critical Component of Modern Healthcare Surgical gloves have become an indispensable element in modern healthcare, serving as a first line of defense against contamination, infection, and disease transmission. These gloves are not just protective gear-they are a symbol of safety, hygiene, and precision in medical practice. Their significance spans from routine hospital procedures to complex surgical interventions, highlighting their essential role in patient care and medical safety protocols. The
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market: Driving Innovation and Transformation in the Clinical Research Landscape The Asia Pacific Contract Research Organization (CRO) market has been witnessing significant growth over the past decade, emerging as a pivotal hub for clinical research and drug development. With a growing population, increasing prevalence of chronic diseases, and rising investments in healthcare infrastructure, the region has become an attractive destination for pharmaceutical and biotechnology companies seeking cost-effective and

All 5 Releases


More Releases for Macular

Elevated Diabetes Prevalence Fuels Growth In The Macular Edema And Macular Degen …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? The market encompassing macular edema and macular degeneration has experienced substantial expansion recently, projected to increase from a value of $9.65 billion in 2024 to $10.33 billion in 2025, reflecting a compound annual growth rate (CAGR)
2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be? The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies. Download White Paper: https://www.towardshealthcare.com/download-statistics/5375 Market Overview and Key Drivers The macular
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $12.84
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The